Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

The electronic structure of atoms and molecules is the series of energy levels that it are possible for a bound electron to occupy. This electronic structure determines many of the defining ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those taking DPP-4 drugs.

The medication, known as Inpefa, offers unique cardiovascular advantages not observed in other SGLT2 inhibitors. In a surprising revelation, it was found that a recently-approved drug for treating ...

When you first enter a new world, you can either spawn near a structure or find one while exploring any of the three dimensions. While finding some can be quite easy, others are extremely hard to ...

Most patients diagnosed with T2D are treated with glucose-lowering medications, such as SGLT-2is, GLP-1RAs, and DPP-4is. It is important to understand how these medications affect people with COPD.

With studies showing potential for SGLT2 inhibitors in heart failure, a study of HCP online conversations reveals cardiologists are still cautious. AstraZeneca had already been quick to consider ...

Get Instant Summarized Text (Gist) Combining the SGLT-2 inhibitor dapagliflozin with moderate calorie restriction significantly increases diabetes remission rates in overweight or obese adults ...

Tubular glucose reabsorption is performed by the combined action of Na + /D-glucose SGLTs co-transporters and GLUT-facilitated diffusion glucose transporters. SGLT2 inhibitors are a new family of ...

Although low-dose dapagliflozin was less effective in preventing hospitalization for heart failure, SGLT-2 inhibitors had similar cardiovascular outcomes in T2D. Canagliflozin and dapagliflozin ...